SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending downward following the announcement of a $3 billion convertible senior note offering and an at-the-market equity program to fund expansion, which traders fear will cause significant shareholder dilution. While some investors see the move as necessary to finance growth and maintain market share, the market's reaction has been overwhelmingly negative, with many criticizing the timing of the news during a period of positive momentum.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing significant volatility and investor attention following a double-upgrade from JPMorgan, which cited strong neocloud momentum and improved pricing power. While bullish sentiment persists around the company's AI data center infrastructure and expansion, trading is being heavily impacted by broader market turbulence, concerns over share dilution, and ongoing debate regarding AI sector valuations.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is trending as traders speculate on positive guidance updates and upcoming clinical data readouts for its lung cancer and TIL pipeline, following a recent price target hike from Barclays. The community sentiment remains strongly bullish, focusing on the company's clear path to profitability, commercial growth for its lead therapy, and the expectation of long-term institutional accumulation.

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group shares are trending following the company's announcement of a roughly 20% price increase for its on-demand NVIDIA GPU compute services, which the community views as strong evidence of robust AI demand and pricing power. While some traders express concern over broader sector volatility, interest rate uncertainty, and potential sympathy moves with peers, sentiment remains largely bullish with many interpreting the price hike as a positive fundamental catalyst.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing stock is trending following CEO Kelly Ortberg's comments at the Morgan Stanley conference, where he acknowledged that stabilizing 737 production is taking longer than anticipated due to wing production constraints. While some traders expressed frustration over the ongoing production delays and the potential for a work stoppage, others characterized the sell-off as an overreaction, pointing to maintained free cash flow guidance and upcoming certifications as long-term catalysts.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI shares are rallying as traders react to positive clinical trial results from Moderna and Merck, which highlight the strategic value of the company's genomic sequencing capabilities and its planned acquisition of Personalis. While some investors see this as a validation of the company's long-term potential in precision oncology and AI-driven diagnostics, others are debating valuation concerns and the impact of the acquisition deal structure.

Generac Holdings, Inc. engages in the business of designing and manufacturing energy technology solutions. It operates under the Domestic and International segments. The Domestic segment includes the legacy Generac business and the acquisitions that are based in the United States and Canada. The International segment focuses on Generac business' Latin American export operations. The company was founded in 1959 and is headquartered in Waukesha, WI.

Generac Holdings Inc

Generac is trending after announcing a landmark long-term supply agreement with Amazon to provide backup generators for data centers, a deal that could be worth up to $8 billion. While some traders debate the potential for dilution from warrants issued to Amazon, sentiment is largely bullish as investors view the partnership as a significant expansion of the company's role in AI infrastructure.

Paramount Skydance Corp. is a next-generation global media and entertainment company that engages in providing content creation and distribution services. It operates through the following business segments: Studios, Direct-to-Consumer, and TV Media. Its portfolio unites brands including Paramount Pictures, Paramount Television, CBS, CBS News, Nickelodeon, MTV, BET, Comedy Central, Showtime, Paramount Plus, Pluto TV, and Skydance’s Animation, Film, Television, Interactive/Games, and Sports divisions. The company is headquartered in New York, NY.

Paramount Skydance Corp. - Ordinary Shares - Class B

Investors are monitoring legal challenges surrounding the merger, specifically focusing on the potential for settlement talks with state attorneys general to avoid a costly daily fee. Discussion also highlights speculation over asset restructuring and potential relocation plans as market participants debate the deal's ultimate completion despite ongoing litigation.

Goodyear Tire & Rubber Co. engages in the development, manufacture, distribution, and sale of tires. It operates through the following geographical segments: Americas, Europe, Middle East, and Africa, and Asia Pacific. The Americas segment is involved in the development, manufacture, distribution, and sale of tires and related products and services in North, Central, and South America. The Europe, Middle East, and Africa segment focuses on the development, manufacture, distribution, and sale of tires for automobiles, trucks, buses, aircraft, motorcycles, earthmoving, mining, and industrial equipment throughout Europe, the Middle East, and Africa. The Asia Pacific segment refers to the development, manufacture, distribution, and sales of tires for automobiles, trucks, buses, aircraft, farm, earthmoving, mining, and industrial equipment throughout the Asia Pacific region. The company was founded by Frank A. Seiberling on August 29, 1898 and is headquartered in Akron, OH.

Goodyear Tire & Rubber Co.

Goodyear is trending as traders speculate on potential buyout interest from high-profile investors or industry competitors, alongside ongoing debate regarding the company's high debt load and sensitivity to oil prices. While some community members view the stock as deeply undervalued and a candidate for acquisition, others express significant pessimism due to poor earnings performance and the impact of input costs on margins.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is trending following the appointment of LVMH executive Alexandre Arnault to its board of directors, an addition investors are monitoring as a potential catalyst for the company's ongoing turnaround efforts. While some traders view the move as a positive development for leadership, sentiment remains largely bearish amid concerns over declining sales and the stock's recent performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The FDA just granted $ELAN an Emergency Use Authorization for CLiK Extra, a wound spray that prevents New World screwworm in livestock and wildlife — from cattle and sheep to bison and Sonoran pronghorn. 
 
Yet shares slipped ~2% on the news. Here&#39;s why 👇 
https://prismmarketview.com/elanco-wins-fda-emergency-authorization-for-new-world-screwworm-drug/

The U.S. Food and Drug Administration on Thursday granted an Emergency Use Authorization (EUA) to Elanco Animal Health (ELAN) for CLiK Extra, a wound spray that

PRISM MarketView

Elanco Wins FDA Emergency Authorization for New World Screwworm Drug

StockTwits Web

Elanco Animal Health Inc

 an Emergency Use Authorization for CLiK Extra, a wound spray that prevents New World screwworm in livestock and wildlife — from cattle and sheep to bison and Sonoran pronghorn. 
 
Yet shares slipped ~2% on the news. Here's why 👇 
